Company

Tisento Therapeutics

Industrydeveloper of novel medicines to treat diseases with significant unmet medical needs, is launching with an $81m Series A financing

Funding raised

CompanyRoundDate
Tisento TherapeuticsSeries A Funding2023-08-01